Good practice statement on the use of variant-containing COVID-19 vaccines

This Good Practice Statement summarizes current evidence on these variant-containing mRNA vaccines and provides guidance on their use in the context of the continued availability of ancestral virus-based COVID-19 vaccines. The recommendations apply to all COVID-19 vaccines; however, at this point only variant-containing mRNA vaccines have received emergency authorization.

Added by: Géraldine Nemrod
Added on: 20 October, 2022
Hits: 108